Erlinge, David

Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trial

James, S., Angiolillo, D. J., Cornel, J. H., Erlinge, D., Husted, S., Kontny, F., Maya, J., Nicolau, J. C., Spinar, J., Storey, R. F., et al. (2010) · European Heart Journal

Antiplatelet Therapy and Cardiovascular DiseasesCoronary Interventions and Diagnostics

Cited by 446

Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments: experiences from the SWEDEHEART registry 1995-2014

Szummer, K., Wallentin, L., Lindhagen, L., Alfredsson, J., Erlinge, D., Held, C., James, S., Kellerth, T., Lindahl, B., Ravn-Fischer, A., et al. (2017) · European Heart Journal

Acute Myocardial Infarction ResearchCoronary Interventions and Diagnostics

Cited by 443

Patients with poor responsiveness to thienopyridine treatment or with diabetes have lower levels of circulating active metabolite, but their platelets respond normally to active metabolite added ex vivo

Erlinge, D., Varenhorst, C., Braun, O. Ö., James, S., Winters, K. J., Jakubowski, J. A., Brandt, J. T., Sugidachi, A., Siegbahn, A., & Wallentin, L. (2008) · Journal of the American College of Cardiology

Antiplatelet Therapy and Cardiovascular DiseasesPlatelet Disorders and Treatments

Cited by 215

Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial

Bhatt, D. L., Steg, P. G., Mehta, S. R., Leiter, L. A., Simon, T., Fox, K., Held, C., Andersson, M., Himmelmann, A., Ridderstråle, W., et al. (2019) · The Lancet

Antiplatelet Therapy and Cardiovascular DiseasesCoronary Interventions and Diagnostics

Cited by 209

Cardiovascular mortality in bipolar disorder: a population-based cohort study in Sweden

Westman, J., Hällgren, J., Wahlbeck, K., Erlinge, D., Alfredsson, L., & Ösby, U. (2013) · BMJ Open

Bipolar Disorder and TreatmentSchizophrenia research and treatment

Cited by 204

Screening for glucose perturbations and risk factor management in dysglycemic patients with coronary artery disease—a persistent challenge in need of substantial improvement: a report from ESC EORP EUROASPIRE V

Ferrannini, G., De Bacquer, D., De Backer, G., Kotseva, K., Mellbin, L., Wood, D., Rydén, L., collaborators, E. V., Gale, C. P., Beleslin, B., et al. (2020) · Diabetes Care

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and Management

Cited by 75

Development of an MRM assay panel with application to biobank samples from patients with myocardial infarction

Rezeli, M., Végvári, Á., Donnarumma, F., Gidlöf, O., Smith, J. G., Erlinge, D., & Marko-Varga, G. (2013) · Journal of Proteomics

Advanced Proteomics Techniques and ApplicationsMetabolomics and Mass Spectrometry Studies

Cited by 33